Keyphrases
Myeloid-derived Suppressor Cells
100%
Tumor
29%
Interleukin-4 (IL-4)
28%
Interleukin-12 (IL-12)
23%
4-1BB
22%
Myeloid Cells
19%
Combination Therapy
19%
Leukocyte Immune-type Receptors
17%
Tumor Immunity
16%
Regulatory T (Treg) Cells
16%
Immune Tolerance
14%
In Cancer
14%
Cell Function
13%
CD8+ T Cells
13%
IL-4 Receptor
12%
Gene Delivery
12%
Signaling Pathway
12%
Immune Suppression
11%
Dendritic Cells
11%
Inositol Phosphatase
11%
Gr-1
11%
Immature Myeloid Cells
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Immunoreceptor Tyrosine-based Activation Motif
11%
LILRB2
10%
In Situ
10%
LILRB3
10%
Oncolytic Viral Therapy
10%
Tumor Immune Microenvironment
10%
Sympathetic Nervous System
10%
CAR T-cell Therapy
10%
Monocyte-derived Cells
10%
Immune Regulation
10%
Sunitinib
10%
Leukemia Progression
10%
Cancer Vaccine
10%
Like Receptors
10%
Acute Myeloid Leukemia
10%
Cancer Treatment
10%
Graft-versus-host Disease (GvHD)
9%
Tumor-bearing Mice
9%
Inhibitory Receptors
9%
Suppressive Function
9%
Tumor Microenvironment
9%
Cell-to-cell
9%
Natural Killer Cells
8%
Tumor-specific
8%
Cell-based
8%
Antitumor Effect
8%
Tumor-bearing Host
8%
Immunology and Microbiology
Myeloid-Derived Suppressor Cell
90%
T Cell
40%
Myeloid
37%
Regulatory T Cell
24%
Immunotherapy
22%
Dendritic Cell
18%
Cell Function
17%
Interleukin 4
17%
Cell Maturation
16%
Cytotoxic T-Cell
15%
Immune Tolerance
14%
Macrophage
13%
Tyrosine
13%
Tumor Vaccine
12%
Interleukin 12
12%
Gene Targeting
11%
Natural Killer Cell
11%
Intravenous Immunoglobulin
11%
Tumor Cell
10%
Colon
10%
Phosphatase
10%
Leukocyte Immunoglobulin-Like Receptors
10%
Immune Response
10%
LILRB2
10%
Sunitinib
10%
Neurological System
10%
Graft-Versus-Host Disease
9%
Immunocompetent Cell
9%
Immunoreceptor Tyrosine-Based Inhibitory Motif
8%
Granulocyte Macrophage Colony-Stimulating Factor
8%
Autoimmune Disease
7%
Clonal Anergy
7%
Antigen Specificity
7%
Antigen Presentation
7%
Gene Transfer
6%
Cell Activation
6%
CD8
6%
Virus
6%
Immunosuppressive Drug
5%
T Cell Activation
5%
Antigen-Presenting Cell
5%
Wild Type
5%
Cell Infiltration
5%
In Vitro
5%
CD4
5%
Recombination Signal Sequences
5%
Cytotoxic T Cell
5%
Interleukin 6
5%
Synergism
5%
CD137 Ligand
5%
Medicine and Dentistry
Neoplasm
35%
Myeloid-Derived Suppressor Cell
33%
Receptor
32%
Myeloid Cell
28%
Immunoglobulin
20%
Leukocyte
17%
Tumor
12%
Malignant Neoplasm
12%
Combination Therapy
10%
Triple Negative Breast Cancer
10%
Tumor Immune Microenvironment
10%
Oncolytic Virotherapy
10%
Cell Maturation
10%
CAR T-cell therapy
10%
Acute Myeloid Leukemia
10%
T Cell
9%
Breast Cancer
9%
Immunocompetent Cell
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Leukemia Cell
8%
Immunotherapy
8%
Graft Versus Host Reaction
7%
Leukemia
7%
Tumor Progression
7%
Clinical Trial
7%
Specific Tumor
7%
Cytotoxic T-Cell
6%
Cell Function
6%
Interleukin 12
6%
Lung Cancer
6%
Graft Versus Leukemia Effect
6%
Gene Targeting
6%
Immunological Tolerance
5%
Hematologic Malignancy
5%
Solid Malignant Neoplasm
5%
Interleukin 6
5%
Antigen Presenting Cell
5%
Non Small Cell Lung Cancer
5%
Immunology
5%
Diseases
5%
Cancer
5%
Ligation
5%
Cell Differentiation
5%
Revertant
5%
Tocilizumab
5%
N(g) Methylarginine
5%
Metastatic Colon Cancer
5%
Stem Cell Factor
5%
Stereotactic Body Radiation Therapy
5%
Pembrolizumab
5%
